Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) shares reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $9.84 and last traded at $9.82, with a volume of 111505 shares trading hands. The stock had previously closed at $9.78.
Cybin Price Performance
The stock has a market capitalization of $1.44 billion and a price-to-earnings ratio of -40.33. The firm’s fifty day moving average is $3.52 and its 200-day moving average is $1.45.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Read More
- Five stocks we like better than Cybin
- Why Invest in High-Yield Dividend Stocks?
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- Stock Sentiment Analysis: How it Works
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Election Stocks: How Elections Affect the Stock Market
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
